Works matching IS 08876924 AND DT 2008 AND VI 22 AND IP 9

Results: 31

Inv(11)(q21q23) fuses MLL to the Notch co-activator mastermind-like 2 in secondary T-cell acute lymphoblastic leukemia.

Published in:

2008

By:

Metzler, M.;
Staege, M. S.;
Harder, L.;
Mendelova, D.;
Zuna, J.;
Fronkova, E.;
Meyer, C.;
Flohr, T.;
Bednarova, D.;
Harbott, J.;
Langer, T.;
Gesk, S.;
Trka, J.;
Siebert, R.;
Dingermann, T.;
Marschalek, R.;
Niemeyer, C.;
Rascher, W.

Publication type:

Correction Notice

Corticosteroids in the prevention of graft-vs-host disease after allogeneic myeloablative stem cell transplantation: a systematic review and meta-analysis.

Published in:

2008

By:

Quellmann, S.;
Schwarzer, G.;
Hübel, K.;
Engert, A.;
Bohlius, J.

Publication type:

Letter

PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML.

Published in:

Leukemia (08876924), 2008, v. 22, n. 9, p. 1698, doi. 10.1038/leu.2008.144

By:

Park, S.;
Chapuis, N.;
Bardet, V.;
Tamburini, J.;
Gallay, N.;
Willems, L.;
Knight, Z. A.;
Shokat, K. M.;
Azar, N.;
Viguié, F.;
Ifrah, N.;
Dreyfus, F.;
Mayeux, P.;
Lacombe, C.;
Bouscary, D.

Publication type:

Article

A pilot pharmacokinetic study of oral azacitidine.

Published in:

2008

By:

Garcia-Manero, G.;
Stoltz, M. L.;
Ward, M. R.;
Kantarjian, H.;
Sharma, S.

Publication type:

journal article

Spongistatin 1: a new chemosensitizing marine compound that degrades XIAP.

Published in:

Leukemia (08876924), 2008, v. 22, n. 9, p. 1737, doi. 10.1038/leu.2008.146

By:

Schyschka, L.;
Rudy, A.;
Jeremias, I.;
Barth, N.;
Pettit, G. R.;
Vollmar, A. M.

Publication type:

Article

Immunotherapy for myeloid leukemias: current status and future directions.

Published in:

2008

By:

el-Shami, K.;
Smith, B. D.

Publication type:

journal article

Prenatal origin of childhood acute lymphoblastic leukemia, association with birth weight and hyperdiploidy.

Published in:

Leukemia (08876924), 2008, v. 22, n. 9, p. 1692, doi. 10.1038/leu.2008.152

By:

Gruhn, B.;
Taub, J. W.;
Ge, Y.;
Beck, J. F.;
Zell, R.;
Häfer, R.;
Hermann, F. H.;
Debatin, K.-M.;
Steinbach, D.

Publication type:

Article

On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia.

Published in:

2008

By:

Feldman, E. J.;
Cortes, J.;
DeAngelo, D. J.;
Holyoake, T.;
Simonsson, B.;
O'Brien, S. G.;
Reiffers, J.;
Turner, A. R.;
Roboz, G. J.;
Lipton, J. H.;
Maloisel, F.;
Colombat, P.;
Martinelli, G.;
Nielsen, J. L.;
Petersdorf, S.;
Guilhot, F.;
Barker, J.;
Kirschmeier, P.;
Frank, E.;
Statkevich, P.

Publication type:

journal article

The dual PI3 kinase/mTOR inhibitor PI-103 prevents p53 induction by Mdm2 inhibition but enhances p53-mediated mitochondrial apoptosis in p53 wild-type AML.

Published in:

2008

By:

Kojima, K.;
Shimanuki, M.;
Shikami, M.;
Samudio, I. J.;
Ruvolo, V.;
Corn, P.;
Hanaoka, N.;
Konopleva, M.;
Andreeff, M.;
Nakakuma, H.

Publication type:

journal article

Incorporation of the bone marker carboxy-terminal telopeptide of type-1 collagen improves prognostic information of the International Staging System in newly diagnosed symptomatic multiple myeloma.

Published in:

Leukemia (08876924), 2008, v. 22, n. 9, p. 1767, doi. 10.1038/leu.2008.159

By:

Jakob, C.;
Sterz, J.;
Liebisch, P.;
Mieth, M.;
Rademacher, J.;
Goerke, A.;
Heider, U.;
Fleissner, C.;
Kaiser, M.;
von Metzler, I.;
Müller, C.;
Sezer, O.

Publication type:

Article

Hematopoietic stem cells and progenitors of chronic myeloid leukemia express leukemia-associated antigens: implications for the graft-versus-leukemia effect and peptide vaccine-based immunotherapy.

Published in:

2008

By:

Yong, A. S. M.;
Keyvanfar, K.;
Eniafe, R.;
Savani, B. N.;
Rezvani, K.;
Sloand, E. M.;
Goldman, J. M.;
Barrett, A. J.

Publication type:

journal article

Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinib.

Published in:

2008

By:

Yang, C.;
Lu, P.;
Lee, F. Y.;
Chadburn, A.;
Barrientos, J. C.;
Leonard, J. P.;
Ye, F.;
Zhang, D.;
Knowles, D. M.;
Wang, Y. L.

Publication type:

journal article

Pharmacokinetic, pharmacodynamic and intracellular effects of PEG-asparaginase in newly diagnosed childhood acute lymphoblastic leukemia: results from a single agent window study.

Published in:

Leukemia (08876924), 2008, v. 22, n. 9, p. 1665, doi. 10.1038/leu.2008.165

By:

Appel, I. M.;
Kazemier, K. M.;
Boos, J.;
Lanvers, C.;
Huijmans, J.;
Veerman, A. J. P.;
van Wering, E.;
den Boer, M. L.;
Pieters, R.

Publication type:

Article

Pathway activation patterns in diffuse large B-cell lymphomas.

Published in:

Leukemia (08876924), 2008, v. 22, n. 9, p. 1746, doi. 10.1038/leu.2008.166

By:

Bentink, S.;
Wessendorf, S.;
Schwaenen, C.;
Rosolowski, M.;
Klapper, W.;
Rosenwald, A.;
Ott, G.;
Banham, A. H.;
Berger, H.;
Feller, A. C.;
Hansmann, M.-L.;
Hasenclever, D.;
Hummel, M.;
Lenze, D.;
Möller, P.;
Stuerzenhofecker, B.;
Loeffler, M.;
Truemper, L.;
Stein, H.;
Siebert, R.

Publication type:

Article

Identification of marker genes including RUNX3 (AML2) that discriminate between different myeloproliferative neoplasms and normal individuals.

Published in:

2008

By:

Müller, C. I.;
Luong, Q. T.;
Shih, L.-Y.;
Jones, L. C.;
Desmond, J. C.;
Kawamata, N.;
Tcherniantchouk, O.;
Liu, Q.;
Ito, K.;
Osato, M.;
Ito, Y.;
Tefferi, A.;
de Vos, S.;
Koeffler, H. P.

Publication type:

Letter

Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia.

Published in:

Leukemia (08876924), 2008, v. 22, n. 9, p. 1685, doi. 10.1038/leu.2008.169

By:

Voso, M. T.;
Hohaus, S.;
Guidi, F.;
Fabiani, E.;
D'Alò, F.;
Groner, S.;
Späth, D.;
Doehner, K.;
Leone, G.;
Doehner, H.;
Schlenk, R. F.

Publication type:

Article

Rac guanosine triphosphatases represent a potential target in AML.

Published in:

2008

By:

Müller, L. U. W.;
Schore, R. J.;
Zheng, Y.;
Thomas, E. K.;
Kim, M.-O.;
Cancelas, J. A.;
Gu, Y.;
Williams, D. A.;
Müller, L U W

Publication type:

Letter

Incorporation of the bone marker carboxy-terminal telopeptide of type-1 collagen improves prognostic information of the International Staging System in newly diagnosed symptomatic multiple myeloma.

Published in:

2008

By:

Jakob, C.;
Sterz, J.;
Liebisch, P.;
Mieth, M.;
Rademacher, J.;
Goerke, A.;
Heider, U.;
Fleissner, C.;
Kaiser, M.;
von Metzler, I.;
Müller, C.;
Sezer, O.

Publication type:

Correction Notice

Pathogenesis and progression of monoclonal gammopathy of undetermined significance.

Published in:

Leukemia (08876924), 2008, v. 22, n. 9, p. 1651, doi. 10.1038/leu.2008.203

By:

Bladé, J.;
Rosiñol, L.;
Cibeira, M. T.;
de Larrea, C. F.

Publication type:

Article

Multiple sub-microscopic genomic lesions are a universal feature of chronic myeloid leukaemia at diagnosis.

Published in:

2008

By:

Khorashad, J. S.;
De Melo, V. A.;
Fiegler, H.;
Gerrard, G.;
Marin, D.;
Apperley, J. F.;
Goldman, J. M.;
Foroni, L.;
Reid, A. G.

Publication type:

Letter

BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cells.

Published in:

Leukemia (08876924), 2008, v. 22, n. 9, p. 1712, doi. 10.1038/leu.2008.175

By:

Pérez-Galán, P.;
Roué, G.;
López-Guerra, M.;
Nguyen, M.;
Villamor, N.;
Montserrat, E.;
Shore, G. C.;
Campo, E.;
Colomer, D.

Publication type:

Article

Association between high expression of natural killer related-genes (NCAM/CD94) and early death during induction in children with acute myeloid leukemia.

Published in:

2008

By:

LoNigro, L.;
Mirabile, E.;
Munda, S.;
Barchitta, M.;
Bottino, D.;
Fazzio, A.;
Di Cataldo, A.;
Agodi, A.;
Schilirò, G.

Publication type:

Letter

Inv(11)(q21q23) fuses MLL to the Notch co-activator mastermind-like 2 in secondary T-cell acute lymphoblastic leukemia.

Published in:

2008

By:

Metzler, M.;
Staege, M. S.;
Harder, L.;
Mendelova, D.;
Zuna, J.;
Fronkova, E.;
Meyer, C.;
Flohr, T.;
Bednarova, D.;
Harbott, J.;
Langer, T.;
Gesk, S.;
Trka, J.;
Siebert, R.;
Dingermann, T.;
Marschalek, R.;
Niemeyer, C.;
Rascher, W.

Publication type:

Letter

Fludarabine combination therapy for follicular lymphoma followed by acute myeloid leukemia: two further case records.

Published in:

2008

By:

Bernardeschi, P.;
Fiorentini, G.;
Dentico, P.;
Rossi, S.;
Turrisi, G.;
Del Conte, A.;
Giannessi, P. G.;
Giustarini, G.;
Montenora, I.

Publication type:

Letter

Successful treatment of multicentric Castleman's disease with combined immunochemotherapy in an AIDS patient with multiorgan failure.

Published in:

2008

By:

Schmidt, S. M.;
Raible, A.;
Kortüm, F.;
Mayer, F.;
Riessen, R.;
Adam, P.;
Gregor, M.;
Bissinger, A. L.

Publication type:

Letter

Allogeneic transplantation of multiple umbilical cord blood units in adults: role of pretransplant-mixed lymphocyte reaction to predict host-vs-graft rejection.

Published in:

2008

By:

Fanning, L. R.;
Hegerfeldt, Y.;
Tary-Lehmann, M.;
Lesniewski, M.;
Maciejewski, J.;
Weitzel, R. P.;
Kozik, M.;
Finney, M.;
Lazarus, H. M.;
Paul, P.;
Ratajczak, M. Z.;
Meyerson, H. J.;
Laughlin, M. J.

Publication type:

Letter

TG101348, a JAK2-selective antagonist, inhibits primary hematopoietic cells derived from myeloproliferative disorder patients with JAK2V617F, MPLW515K or JAK2 exon 12 mutations as well as mutation negative patients.

Published in:

2008

By:

Lasho, T. L.;
Tefferi, A.;
Hood, J. D.;
Verstovsek, S.;
Gilliland, D. G.;
Pardanani, A.

Publication type:

Letter

BIC is processed efficiently to microRNA-155 in Burkitt lymphoma cells.

Published in:

2008

By:

Zhang, T.;
Nie, K.;
Tam, W.

Publication type:

Letter

Transformation of severe congenital neutropenia to early acute lymphoblastic leukemia in a patient with HAX1 mutation and without G-CSF administration or receptor mutation.

Published in:

2008

By:

Yetgin, S.;
Olcay, L.;
Koç, A.;
Germeshausen, M.

Publication type:

Letter

Polymorphisms in folate-related genes: association with side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia.

Published in:

2008

By:

Huang, L.;
Tissing, W. J. E.;
de Jonge, R.;
van Zelst, B. D.;
Pieters, R.

Publication type:

Letter

Two cell lines of t(8;21) acute myeloid leukemia with activating KIT exon 17 mutation: models for the ‘second hit’ hypothesis.

Published in:

2008

By:

Becker, H.;
Pfeifer, D.;
Afonso, J. D.;
Nimer, S. D.;
Veelken, H.;
Schwabe, M.;
Lübbert, M.

Publication type:

Letter